<--- Back to Details
First PageDocument Content
Drug eruptions / Angioedema / Acquired C1 esterase inhibitor deficiency / Hereditary angioedema / C1-inhibitor / CSL Behring / Complement deficiency / Health / Medicine
Date: 2012-04-03 12:17:59
Drug eruptions
Angioedema
Acquired C1 esterase inhibitor deficiency
Hereditary angioedema
C1-inhibitor
CSL Behring
Complement deficiency
Health
Medicine

Microsoft Word - HAE Emergency_Flowchart_PINUK.doc

Add to Reading List

Source URL: www.haeuk.org

Download Document from Source Website

File Size: 20,08 KB

Share Document on Facebook

Similar Documents

Medicine / Health / Complement deficiency / Clinical medicine / Angioedema / Adverse effect / Hereditary angioedema

[Product Monograph Template - Schedule D]

DocID: 1qWQL - View Document

Blood / Coagulation system / Anatomy / CSL Behring / Von Willebrand disease / Factor VIII / Coagulation / CSL Limited / Hereditary angioedema / Haemophilia / Factor IX / Factor VII

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

Neurochemistry / Medicine / Clinical medicine / Complement deficiency / RTT / Sodium channel blockers / Euphoriants / Calcium channel blockers / Hereditary angioedema / Syringe / Angioedema / Ketamine

Microsoft Word - CINRYZE.Product Monographdoc

DocID: 1qE2h - View Document

Medicine / Health / Clinical medicine / Clinical pharmacology / GABAA receptor positive allosteric modulators / Complement deficiency / Hereditary angioedema / Serpinopathies / Icatibant / Adverse effect / Clinical trial / Zolpidem

Microsoft Word - FIRAZYR.Product Monographdoc

DocID: 1qA9x - View Document

Medicine / CSL Behring / Clinical medicine / Microbiology / Coagulation system / CSL Limited / Hereditary angioedema / Behring / CSL / Coagulation / Marburg

Fact Sheet CSL BehringCSL Sales $5.5 Billion CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop

DocID: 1pVHk - View Document